The Effect of Tirzepatide versus Dulaglutide on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes (SURPASS-CVOT)
Clinical Trial Grant
Administered By
Medicine, Endocrinology, Metabolism, and Nutrition
Awarded By
Eli Lilly and Company
Start Date
September 1, 2020
End Date
July 31, 2025
Administered By
Medicine, Endocrinology, Metabolism, and Nutrition
Awarded By
Eli Lilly and Company
Start Date
September 1, 2020
End Date
July 31, 2025